Marsha Y. Morgan, FRCP

Affiliations: 
Medicine University College London, London, United Kingdom 
Area:
Metabolic Encephalopathy
Google:
""Marsha Y Morgan""
Mean distance: 18.9 (cluster 56)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Olesen SS, Jackson CD, Gram M, et al. (2018) Cortical networks are disturbed in people with cirrhosis even in the absence of neuropsychometric impairment. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Goh ET, Stokes CS, Sidhu SS, et al. (2018) L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane Database of Systematic Reviews. 5: CD012410
Olesen SS, Jackson CD, Morgan MY. (2017) Tools and tactics for improving diagnosis of hepatic encephalopathy. Journal of Hepatology
Zacharias HD, Jackson CD, Morgan MY, et al. (2017) Letter: stepwise diagnosis in covert hepatic encephalopathy - critical flicker frequency and MELD-score as a first-step approach. Replication and pitfalls. Alimentary Pharmacology & Therapeutics. 45: 187-189
Morgan MY. (2016) Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides. Metabolic Brain Disease
Grover VP, McPhail MJ, Wylezinska-Arridge M, et al. (2016) A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy. Metabolic Brain Disease
Jackson CD, Gram M, Halliday E, et al. (2016) New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Olesen SS, Gram M, Jackson CD, et al. (2016) Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy. Journal of Hepatology
Gluud LL, Vilstrup H, Morgan MY. (2016) Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane Database of Systematic Reviews. 5: CD003044
Gluud LL, Vilstrup H, Morgan MY. (2016) Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane Database of Systematic Reviews. 4: CD003044
See more...